711 related articles for article (PubMed ID: 20223018)
1. Selected Aspects of Molecular Diagnostics of Constitutional Alterations in BRCA1 and BRCA2 Genes Associated with Increased Risk of Breast Cancer in the Polish Population.
Górski B
Hered Cancer Clin Pract; 2006 Aug; 4(3):142-52. PubMed ID: 20223018
[TBL] [Abstract][Full Text] [Related]
2. High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patients.
Suspitsin EN; Sherina NY; Ponomariova DN; Sokolenko AP; Iyevleva AG; Gorodnova TV; Zaitseva OA; Yatsuk OS; Togo AV; Tkachenko NN; Shiyanov GA; Lobeiko OS; Krylova NY; Matsko DE; Maximov SY; Urmancheyeva AF; Porhanova NV; Imyanitov EN
Hered Cancer Clin Pract; 2009 Feb; 7(1):5. PubMed ID: 19338682
[TBL] [Abstract][Full Text] [Related]
3. The Prevalence of Founder Mutations among Individuals from Families with Familial Pancreatic Cancer Syndrome.
Lener MR; Kashyap A; Kluźniak W; Cybulski C; Soluch A; Pietrzak S; Huzarski T; Gronwald J; Lubiński J
Cancer Res Treat; 2017 Apr; 49(2):430-436. PubMed ID: 27488870
[TBL] [Abstract][Full Text] [Related]
4. BRCA1 founder mutations do not contribute to increased risk of gastric cancer in the Polish population.
Ławniczak M; Jakubowska A; Białek A; Lubiński J; Jaworska-Bieniek K; Kaczmarek K; Starzyńska T
Hered Cancer Clin Pract; 2016; 14():3. PubMed ID: 26779294
[TBL] [Abstract][Full Text] [Related]
5. Recurrent mutations of BRCA1 and BRCA2 in Poland: an update.
Szwiec M; Jakubowska A; Górski B; Huzarski T; Tomiczek-Szwiec J; Gronwald J; Dębniak T; Byrski T; Kluźniak W; Wokołorczyk D; Birkenfeld B; Akbari MR; Narod SA; Lubiński J; Cybulski C
Clin Genet; 2015 Mar; 87(3):288-92. PubMed ID: 24528374
[TBL] [Abstract][Full Text] [Related]
6. Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer.
Górski B; Byrski T; Huzarski T; Jakubowska A; Menkiszak J; Gronwald J; Pluzańska A; Bebenek M; Fischer-Maliszewska L; Grzybowska E; Narod SA; Lubiński J
Am J Hum Genet; 2000 Jun; 66(6):1963-8. PubMed ID: 10788334
[TBL] [Abstract][Full Text] [Related]
7. Do founder mutations characteristic of some cancer sites also predispose to pancreatic cancer?
Lener MR; Scott RJ; Kluźniak W; Baszuk P; Cybulski C; Wiechowska-Kozłowska A; Huzarski T; Byrski T; Kładny J; Pietrzak S; Soluch A; Jakubowska A; Lubiński J
Int J Cancer; 2016 Aug; 139(3):601-6. PubMed ID: 27038244
[TBL] [Abstract][Full Text] [Related]
8. A high proportion of founder BRCA1 mutations in Polish breast cancer families.
Górski B; Jakubowska A; Huzarski T; Byrski T; Gronwald J; Grzybowska E; Mackiewicz A; Stawicka M; Bebenek M; Sorokin D; Fiszer-Maliszewska Ł; Haus O; Janiszewska H; Niepsuj S; Góźdź S; Zaremba L; Posmyk M; Płuzańska M; Kilar E; Czudowska D; Waśko B; Miturski R; Kowalczyk JR; Urbański K; Szwiec M; Koc J; Debniak B; Rozmiarek A; Debniak T; Cybulski C; Kowalska E; Tołoczko-Grabarek A; Zajaczek S; Menkiszak J; Medrek K; Masojć B; Mierzejewski M; Narod SA; Lubiński J
Int J Cancer; 2004 Jul; 110(5):683-6. PubMed ID: 15146557
[TBL] [Abstract][Full Text] [Related]
9. [The prevalence of BRCA1 mutations among families at high-risk of breast and ovarian cancer in province of Malopolska between 2004-2009].
Blecharz P; Szatkowski W; Klimek M; Urbański K
Przegl Lek; 2009; 66(12):1046-8. PubMed ID: 20514903
[TBL] [Abstract][Full Text] [Related]
10. Large BRCA1 and BRCA2 genomic rearrangements in Polish high-risk breast and ovarian cancer families.
Rudnicka H; Debniak T; Cybulski C; Huzarski T; Gronwald J; Lubinski J; Gorski B
Mol Biol Rep; 2013 Dec; 40(12):6619-23. PubMed ID: 24065545
[TBL] [Abstract][Full Text] [Related]
11. Germline mutations in the BRCA1 gene predisposing to breast and ovarian cancers in Upper Silesia population.
Grzybowska E; Siemińska M; Zientek H; Kalinowska E; Michalska J; Utracka-Hutka B; Rogozińska-Szczepka J; Kaźmierczak-Maciejewska M
Acta Biochim Pol; 2002; 49(2):351-6. PubMed ID: 12362976
[TBL] [Abstract][Full Text] [Related]
12. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.
Levy-Lahad E; Catane R; Eisenberg S; Kaufman B; Hornreich G; Lishinsky E; Shohat M; Weber BL; Beller U; Lahad A; Halle D
Am J Hum Genet; 1997 May; 60(5):1059-67. PubMed ID: 9150153
[TBL] [Abstract][Full Text] [Related]
13. Hereditary ovarian cancer in Poland.
Menkiszak J; Gronwald J; Górski B; Jakubowska A; Huzarski T; Byrski T; Foszczyńska-Kłoda M; Haus O; Janiszewska H; Perkowska M; Brozek I; Grzybowska E; Zientek H; Góźdź S; Kozak-Klonowska B; Urbański K; Miturski R; Kowalczyk J; Pluzańska A; Niepsuj S; Koc J; Szwiec M; Drosik K; Mackiewicz A; Lamperska K; Strózyk E; Godlewski D; Stawicka M; Waśko B; Bebenek M; Rozmiarek A; Rzepka-Górska I; Narod SA; Lubiński J
Int J Cancer; 2003 Oct; 106(6):942-5. PubMed ID: 12918074
[TBL] [Abstract][Full Text] [Related]
14. Frequency and spectrum of founder and non-founder BRCA1 and BRCA2 mutations in a large series of Russian breast cancer and ovarian cancer patients.
Sokolenko AP; Sokolova TN; Ni VI; Preobrazhenskaya EV; Iyevleva AG; Aleksakhina SN; Romanko AA; Bessonov AA; Gorodnova TV; Anisimova EI; Savonevich EL; Bizin IV; Stepanov IA; Krivorotko PV; Berlev IV; Belyaev AM; Togo AV; Imyanitov EN
Breast Cancer Res Treat; 2020 Nov; 184(1):229-235. PubMed ID: 32776218
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.
Walsh T; Casadei S; Coats KH; Swisher E; Stray SM; Higgins J; Roach KC; Mandell J; Lee MK; Ciernikova S; Foretova L; Soucek P; King MC
JAMA; 2006 Mar; 295(12):1379-88. PubMed ID: 16551709
[TBL] [Abstract][Full Text] [Related]
16. An inherited NBN mutation is associated with poor prognosis prostate cancer.
Cybulski C; Wokołorczyk D; Kluźniak W; Jakubowska A; Górski B; Gronwald J; Huzarski T; Kashyap A; Byrski T; Dębniak T; Gołąb A; Gliniewicz B; Sikorski A; Switała J; Borkowski T; Borkowski A; Antczak A; Wojnar L; Przybyła J; Sosnowski M; Małkiewicz B; Zdrojowy R; Sikorska-Radek P; Matych J; Wilkosz J; Różański W; Kiś J; Bar K; Bryniarski P; Paradysz A; Jersak K; Niemirowicz J; Słupski P; Jarzemski P; Skrzypczyk M; Dobruch J; Domagała P; Narod SA; Lubiński J;
Br J Cancer; 2013 Feb; 108(2):461-8. PubMed ID: 23149842
[TBL] [Abstract][Full Text] [Related]
17. Age at onset of bilateral breast cancer, the presence of hereditary BRCA1, BRCA2, CHEK2 gene mutations and positive family history of cancer.
Skasko E; Kluska A; Niwińska A; Kwiatkowska E; Bałabas A; Piatkowska M; Dabrowska M; Nowakowska D; Pieńkowski T
Onkologie; 2009 Apr; 32(4):182-8. PubMed ID: 19372713
[TBL] [Abstract][Full Text] [Related]
18. [Germline mutation of BRCA1 gene in Polish families with strong aggregation of breast and/or ovarian cancer based on coding sequence analysis using the SSCP method].
Byrski T
Ann Acad Med Stetin; 2003; 49():27-43. PubMed ID: 15552838
[TBL] [Abstract][Full Text] [Related]
19. High incidence of 4153delA BRCA1 gene mutations in Lithuanian breast- and breast-ovarian cancer families.
Gronwald J; Elsakov P; Górski B; Lubiński J
Breast Cancer Res Treat; 2005 Nov; 94(2):111-3. PubMed ID: 16261409
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]